Terms: = Kidney tumors AND MYH9, P35579, 4627, ENSG00000100345, DFNA17
4 results:
1. Epigenetic silencing
Du Q; Zhang M; Gao A; He T; Guo M
Cancer Biol Ther; 2024 Dec; 25(1):2302924. PubMed ID: 38226836
[TBL] [Abstract] [Full Text] [Related]
2. Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer.
Hińcza K; Kowalik A; Kowalska A
Genes (Basel); 2019 Jun; 10(7):. PubMed ID: 31247975
[TBL] [Abstract] [Full Text] [Related]
3. myh9: Structure, functions and role of non-muscle myosin IIA in human disease.
Pecci A; Ma X; Savoia A; Adelstein RS
Gene; 2018 Jul; 664():152-167. PubMed ID: 29679756
[TBL] [Abstract] [Full Text] [Related]
4. The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro.
Piskareva O; Harvey H; Nolan J; Conlon R; Alcock L; Buckley P; Dowling P; Henry M; O'Sullivan F; Bray I; Stallings RL
Cancer Lett; 2015 Aug; 364(2):142-55. PubMed ID: 25960282
[TBL] [Abstract] [Full Text] [Related]
